Add office photos
Engaged Employer
Dr. Reddy's
4.0
based on 7k Reviews
Video summary
Company Overview
Associated Companies
Company Locations
Working at Dr. Reddy's
Company Summary
We are a global pharmaceutical company headquartered in Hyderabad, India. Driven by our purpose of ‘Good Health Can’t Wait’
Overall Rating
4.0/5
based on 7k reviews
3% above
industry average
Highly rated for
Skill development, Company culture, Salary
Critically rated for
Promotions
Work Policy
Work from office
75% employees reported
Monday to Friday
39% employees reported
Flexible timing
67% employees reported
Within city
37% employees reported
View detailed work policy
Top Employees Benefits
Job/Soft skill training
490 employees reported
Health insurance
410 employees reported
Cafeteria
278 employees reported
Child care facility
261 employees reported
View all benefits
About Dr. Reddy's
Founded in1984 (41 yrs old)
India Employee Count10k-50k
Global Employee Count10k-50k
India HeadquartersHyderabad/Secunderabad, Telangana, India
Office Locations
Websitedrreddys.com
Primary Industry
Other Industries
View in video summary
We started in 1984 with a modest investment and a bold vision. Today, with research and development centres, manufacturing facilities and commercial presence across the globe, we serve over half a billion patients worldwide. We aspire to triple our reach and touch over 1.5 billion patients by 2030.
We are committed to providing access to affordable and innovative medicines, driven by our purpose of ‘Good Health Can’t Wait’.
Our products and services are spread across our core businesses of Active Pharmaceutical Ingredients (API), generics, branded generics, biosimilars and over-the-counter pharmaceutical products around the world. We work towards meeting unmet patients needs in the areas of gastro-enterology, cardiovascular, diabetology, oncology, pain management and dermatology. We are investing in businesses of the future including drug discovery, clinically-differentiated assets and digital healthcare.
Dr. Reddy's Ratings
based on 7k reviews
Overall Rating
4.0/5
How AmbitionBox ratings work?
5
3.6k
4
1.9k
3
722
2
282
1
411
Category Ratings
4.0
Skill development
3.9
Company culture
3.8
Salary
3.8
Work-life balance
3.7
Work satisfaction
3.6
Job security
3.3
Promotions
Dr. Reddy's is rated 4.0 out of 5 stars on AmbitionBox, based on 7k company reviews. This rating reflects a generally positive employee experience, indicating satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at Dr. Reddy's
based on 6.6k reviews
4.0
Rated by 785 Women
Rated 3.9 for Company culture and 3.8 for Work-life balance
4.1
Rated by 5.9k Men
Rated 4.0 for Skill development and 3.9 for Work-life balance
Work Policy at Dr. Reddy's
based on 866 reviews in last 6 months
Work from office
75%
Hybrid
21%
Permanent work from home
4%
Dr. Reddy's Reviews
Top mentions in Dr. Reddy's Reviews
+ 5 more
Compare Dr. Reddy's with Similar Companies
Change Company | Change Company | Change Company | ||
|---|---|---|---|---|
Overall Rating | 4.0/5 based on 7k reviews | 4.1/5 based on 6.1k reviews | 4.1/5 based on 6.1k reviews | 4.1/5 based on 7.1k reviews |
Highly Rated for | Skill development Company culture Work-life balance | Salary Skill development Job security | Skill development Company culture Work-life balance | Skill development Salary Work-life balance |
Critically Rated for | Promotions | No critically rated category | No critically rated category | No critically rated category |
Primary Work Policy | Work from office 75% employees reported | Work from office 82% employees reported | Work from office 85% employees reported | Work from office 74% employees reported |
Rating by Women Employees | 4.0 Good rated by 785 women | 4.0 Good rated by 392 women | 4.0 Good rated by 374 women | 4.0 Good rated by 708 women |
Rating by Men Employees | 4.1 Good rated by 5.9k men | 4.1 Good rated by 5.1k men | 4.2 Good rated by 5.5k men | 4.1 Good rated by 6k men |
Job security | 3.6 Good | 3.9 Good | 3.7 Good | 3.7 Good |
View more
Dr. Reddy's Salaries
Dr. Reddy's salaries have received with an average score of 3.8 out of 5 by 7k employees.
Team Member
(3.9k salaries)
Unlock
₹1.9 L/yr - ₹9.7 L/yr
Analytical Scientist
(820 salaries)
Unlock
₹3.6 L/yr - ₹12.5 L/yr
Senior Team Member
(524 salaries)
Unlock
₹3.8 L/yr - ₹13 L/yr
Team Lead
(453 salaries)
Unlock
₹7 L/yr - ₹24.4 L/yr
Area Sales Manager
(445 salaries)
Unlock
₹4.8 L/yr - ₹12.8 L/yr
Scientist
(325 salaries)
Unlock
₹4 L/yr - ₹13 L/yr
Territory Manager
(310 salaries)
Unlock
₹2.6 L/yr - ₹7.2 L/yr
Production Specialist
(291 salaries)
Unlock
₹3.2 L/yr - ₹7.5 L/yr
Formulation Scientist
(258 salaries)
Unlock
₹4.2 L/yr - ₹12 L/yr
Research Associate
(251 salaries)
Unlock
₹2.2 L/yr - ₹9.8 L/yr
Dr. Reddy's Interview Questions
Interview questions by designation
Top Dr. Reddy's interview questions and answers
Get interview-ready with top interview questions
Dr. Reddy's Jobs
Popular Designations Dr. Reddy's Hires for
Team Member
Create job alerts
Territory Sales Executive
Create job alerts
Territory Manager
Create job alerts
Product Manager
Create job alerts
Product Management Manager
Create job alerts
Group Product Manager
Create job alerts
Quality Controller
Create job alerts
Team Lead
Create job alerts
Territory Business Manager
Create job alerts
Process Engineer
Create job alerts
Dr. Reddy's News
View all
Indian pharma stocks plummet over 4% amid tariff threats from Trump
- Indian pharma stocks plunged over 4% following tariff threats from Donald Trump.
- Trump mentioned that the pharma tariffs will be announced soon.
- The pharma index was the top sectoral loser on the Nifty 50, down by about 1.2%.
- All constituents of the pharma index, including Sun Pharma, Dr Reddy's, and Cipla, traded in the red.
HinduBusinessLine | 4 Apr, 2025
Navigating US Tariff Hikes: Jefferies Lists Sectors At Risk, Potential Gainers
- The auto industry, including companies like Tata Motors Ltd., and auto components manufacturers such as Bharat Forge Ltd. and Sona BLW Precision Forgings Ltd., could face difficulties due to higher tariffs.
- Generic pharmaceutical companies like Zydus Lifesciences Ltd., Dr. Reddy’s Laboratories Ltd., and Lupin Ltd., which rely heavily on the US market, may also be affected.
- Sectors like chemicals, IT, and ports may experience limited impact, as their exposure to US imports is lower.
- In the consumer goods sector, the potential trade deals and reduced input costs could benefit select companies, offsetting broader tariff challenges.
Bloomberg Quint | 28 Mar, 2025
Nifty Top Gainers, Losers On March 25: From UltraTech, Trent To IndusInd Bank, Dr Reddy's
- UltraTech Cement Ltd. and Trent Ltd. were the top gainers on the NSE Nifty 50 on March 25.
- IndusInd Bank Ltd. and Dr Reddy's Laboratories Ltd. were the top losers of the day.
- Bajaj Finserv Ltd. and Grasim Industries Ltd. also closed the day with gains.
- The Nifty ended with a marginal gain of 0.04%, while the BSE Sensex closed slightly up at 78,017.19.
Bloomberg Quint | 25 Mar, 2025
Top gainers & losers intraday March 25, 2025: Sensex, Nifty trades flat, UltraTech, HDFC Bank lead gains
- IT stocks continue to drive the broader index, while other sectors decline.
- UltraTech, HDFC Bank lead the gains, with UltraTech stock trading 3.50% higher and HDFC Bank shares up 1.76%.
- IndusInd, Dr Reddy’s, Hindalco Industries, ICICI Bank, and Coal India are among the losers.
- Bajaj Finance, Kotak Mahindra, and JSW Holdings among the stocks hitting a 52-week high.
HinduBusinessLine | 25 Mar, 2025
Stock Market Highlights: Sensex, Nifty End Higher Tracking Global Cues; Dr. Reddy's Labs Top Gainer
- Indian benchmark equity indices ended higher, tracking global markets.
- Nifty 50 ended 0.5% higher, while Sensex closed up 0.46%.
- Dr. Reddy's Laboratories Ltd. and Bajaj Finserv Ltd. were the top gainers.
- Pharma stocks gained as BofA said the impact from 10% tariff on pharma from the US will be manageable.
Bloomberg Quint | 17 Mar, 2025
Top gainers & losers intraday March 17, 2025: SBI Life, Dr Reddy’s Lab lead gains, Ola Electric, MobiKwik, Hyundai hits 52-week low
- Pharma and banking stocks gained, while oil & gas, IT, and FMCG stocks slipped.
- SBI Life Insurance and Dr Reddy’s Laboratories were the top gainers on the Nifty 50.
- BPCL, Britannia, Wipro, Hero Motocorp, and Asian Paints were among the top losers.
- MobiKwik, Ola Electric, Happiest Minds, LTIMindtree, and Hyundai Motor India hit a 52-week low.
HinduBusinessLine | 17 Mar, 2025
Stocks To Watch Today: IndusInd Bank, Tata Motors, Dr Reddy's, Brigade Enterprises, Hitachi Energy
- IndusInd Bank shares placed under short-term additional surveillance measure (Stage 1) as HDFC Mutual Funds' total stake exceeded 5%.
- The US FDA did not issue a form 483 after the bioresearch monitoring inspection at Alkem Laboratories' bioequivalence centre.
- GR Infraprojects emerged as the bidder for a Rs 4,263 crore order from National Highways Authority of India.
- Dr Reddy's Laboratories issued a nationwide recall of levetiracetam in the US due to mislabeling of an infusion bag.
Bloomberg Quint | 17 Mar, 2025
Dr Reddy's Recalls Epilepsy Drug Levetiracetam In US Over Mislabelling Concerns
- Dr Reddy's Laboratories Ltd. is recalling one batch of epilepsy drug Levetiracetam in 0.75% sodium chloride injection in the US over mislabelling concerns.
- The mislabeled product could lead to serious side effects including hypersensitivity reactions, liver injury, and respiratory depression.
- The affected batch was distributed nationwide in the US between Nov. 4 and Nov. 6 to wholesalers.
- The drug is used as adjunctive therapy for adults in the treatment of seizure types such as partial-onset seizures and primary generalised tonic-clonic seizures.
Bloomberg Quint | 13 Mar, 2025
Senores Pharma To Acquire 14 Abbreviated New Drug Applications From Dr Reddy's Laboratories
- Senores Pharmaceuticals to acquire 14 Abbreviated New Drug Applications from Dr Reddy's Laboratories.
- The acquisition includes 13 ANDAs approved by the USFDA with one application pending approval.
- The addressable opportunity of the acquired ANDAs in the US is around $421 million.
- The acquisition will be funded through the initial public offer proceeds, in line with the objectives of the IPO.
Bloomberg Quint | 4 Mar, 2025
Senores Pharmaceuticals acquires 14 ANDAs from Dr Reddy’s
- Senores Pharmaceuticals has acquired 14 ANDAs from Dr Reddy’s.
- The acquisition package includes 13 USFDA-approved applications and one pending approval.
- The deal represents a market opportunity of approximately $421 million based on IQVIA data and $1.13 billion according to Symphony data.
- Senores Pharmaceuticals plans to finance the acquisition using proceeds from its recent initial public offering.
HinduBusinessLine | 4 Mar, 2025
Powered by
Dr. Reddy's Subsidiaries
Aurigene Oncology Limited
4.3
• 251 reviews
Aurigene Pharmaceutical Services
4.2
• 245 reviews
SVAAS Wellness
3.7
• 14 reviews
Report error
Dr. Reddy's Offices
Compare Dr. Reddy's with
Sun Pharmaceutical Industries
4.0
Aurobindo Pharma
4.0
Intas Pharmaceuticals
4.1
Hetero
3.9
Viatris
4.1
Alembic Pharmaceuticals
4.0
Abbott
4.1
Glenmark Pharmaceuticals
3.9
Alkem Laboratories
3.9
Ipca Laboratories
3.9
Torrent Pharmaceuticals
3.9
Mankind Pharma
3.9
MSN Laboratories
3.7
Ajanta Pharma
4.0
Akums Drugs & Pharmaceuticals Limited
4.4
GlaxoSmithKline Pharmaceuticals
4.1
Pfizer
4.0
DIVI'S Laboratories
3.7
Wockhardt
3.9
Sanofi
4.2
Contribute & help others!
You can choose to be anonymous
Companies Similar to Dr. Reddy's
Zydus Lifesciences
Biotech & Life sciences, Pharma
4.1
• 6.1k reviews
Sun Pharmaceutical Industries
Healthcare / Pharma, Manufacturing, Analytics & KPO, Pharma
4.0
• 5.9k reviews
Aurobindo Pharma
Healthcare / Pharma, Biotechnology, Pharma
4.0
• 4.9k reviews
Intas Pharmaceuticals
Biotech & Life sciences, Pharma
4.1
• 3.5k reviews
Alembic Pharmaceuticals
Real Estate, Engineering & Construction, Biotechnology, Pharma
4.0
• 3.2k reviews
Abbott
Healthcare / Pharma, Media & Entertainment / Publishing, Pharma
4.1
• 3.1k reviews
Glenmark Pharmaceuticals
Pharma
3.9
• 2.9k reviews
Alkem Laboratories
Healthcare / Pharma, Biotechnology, Pharma
3.9
• 2.9k reviews
Dr. Reddy's FAQs
When was Dr. Reddy's founded?
Dr. Reddy's was founded in 1984. The company has been operating for 41 years primarily in the Pharma sector.
Where is the Dr. Reddy's headquarters located?
Dr. Reddy's is headquartered in Hyderabad/Secunderabad, Telangana. It operates in 6 cities such as Hyderabad / Secunderabad, Visakhapatnam, Baddi, Srikakulam, Bangalore / Bengaluru. To explore all the office locations, visit Dr. Reddy's locations.
How many employees does Dr. Reddy's have in India?
Dr. Reddy's currently has more than 21,000+ employees in India. Research & Development department appears to have the highest employee count in Dr. Reddy's based on the number of reviews submitted on AmbitionBox.
Does Dr. Reddy's have good work-life balance?
Dr. Reddy's has a Work-Life Balance Rating of 3.8 out of 5 based on 6,900+ employee reviews on AmbitionBox. 80% employees rated Dr. Reddy's 4 or above, while 20% employees rated it 3 or below on work-life balance. This indicates that the majority of employees feel a generally balanced work-life experience, with some opportunities for improvement based on the feedback. We encourage you to read Dr. Reddy's work-life balance reviews for more details
Is Dr. Reddy's good for career growth?
Career growth at Dr. Reddy's is rated as moderate, with a promotions and appraisal rating of 3.3. 20% employees rated Dr. Reddy's 3 or below, while 80% employees rated it 4 or above on promotions/appraisal. This rating suggests that while some employees view growth opportunities favorably, there is scope for improvement based on employee feedback. We recommend reading Dr. Reddy's promotions/appraisals reviews for more detailed insights.
What are the pros and cons of working in Dr. Reddy's?
Working at Dr. Reddy's comes with several advantages and disadvantages. It is highly rated for skill development, company culture and salary & benefits. However, it is poorly rated for promotions / appraisal, based on 6,900+ employee reviews on AmbitionBox.
Stay ahead in your career. Get AmbitionBox app
Helping over 1 Crore job seekers every month in choosing their right fit company
75 Lakh+
Reviews
5 Lakh+
Interviews
4 Crore+
Salaries
1 Cr+
Users/Month
Contribute to help millions
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2024 Info Edge (India) Ltd.
Follow us
